Endocrine Abstracts

Contents

• BES 2025
• • CLINICAL STUDIES
  • • Real-world evidence of the effect of adjunctive semaglutide on weight change, glycaemic control, and metabolic dysfunction associated steatotic liver disease in people with type 1 diabetes

      ea0112001
    • Continuous glucose monitoring metrics and pregnancy outcomes in type 1 diabetes: a secondary analysis of the cristal trial

      ea0112002
    • Who benefits most from advanced hybrid closed loop therapy in pregnancy based on baseline characteristics? a secondary analysis of the CRISTAL trial

      ea0112003
    • Correlations between fear and perception of hypoglycemia and continuous glucose monitoring metrics in adults with type 1 diabetes using diabetes technology: a one-year retrospective study

      ea0112004
    • Inflammatory stimuli induce profound transcriptome and translatome changes in induced pluripotent stem cell-derived [beta] cells that mimic type 1 diabetes [beta]cell gene signatures

      ea0112005
    • The value of free cortisol estimates in healthy individuals undergoing an insulin tolerance test and synacthen test to evaluate adrenal function

      ea0112006
    • Effect of elexacaftor-tezacaftor-ivacaftor on glucose metabolism in patients with cystic fibrosis

      ea0112007
    • Exploration of phenotypic age in gender-affirming hormone therapy

      ea0112008
    • The one-hour oral glucose tolerance test to predict glucose intolerance postpartum in women with prior gestational diabetes

      ea0112009
    • GLP-1 receptor agonists for weight loss in adults without diabetes: perspectives from primary care

      ea0112010
    • Evaluation of predictive clinical and biological factors for weight reduction and metabolic improvement following remission of Cushing's syndrome

      ea0112011
    • Relationship between macrovascular complications and time in range in adults with type 1 diabetes

      ea0112012
    • Directly measured free testosterone may better predict sexual symptoms of hypogonadism than calculated approximations

      ea0112013
    • One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an advanced hybrid closed-loop system: a real-world prospective cohort study

      ea0112014
    • Role of steroid hormone-binding proteins on the bioactivity of 11-oxygenated androgens

      ea0112015
    • Graves' orbitopathy: burden of the disease in the belgian patient population

      ea0112016
    • Discrepancy between haemoglobine A1c and continuous glucose monitoring derived glucose management indicator and its link to microvascular complications in type 1 diabetes

      ea0112017
    • Vascularization of islet organoids derived from human pluripotent stem cells

      ea0112018
    • Levothyroxine use in belgium in 2003-2020: a longitudinal population-level registry-based cohort analysis

      ea0112019
    • The use of rapid on-site evaluation during thyroid fine needle aspiration might help improve samples representativity

      ea0112020
    • HbA1c-GMI relative gap as emerging risk factor for early onset retinopathy in type 1 diabetes

      ea0112021
  • CLINICAL CASE REPORTS
  • • Malignant hypertension and pseudohyperaldosteronism associated with rifampicin therapy

      ea0112022
    • Severe hypocalcemia due to osteoblastic bone metastases in a patient with hypoparathyroidism: a case report

      ea0112023
    • Macroprolactinoma revealed by progressive vision loss at the end of pregnancy

      ea0112024
    • Severe hyperglycemia induced by enfortumab vedotin: a case report

      ea0112025
    • Endoscopic ultrasound-guided trans-gastric radiofrequency ablation: an effective and safe alternative treatment for left-sided unilateral aldosterone-producing adenoma

      ea0112026
    • A case of steroid-resistant dysthyroid optic neuropathy treated with teprotumumab

      ea0112027
    • A rare cause of glucosuria and aminoaciduria in a patient with well-controlled diabetes mellitus

      ea0112028
    • Severe first-trimester thyrotoxicosis in pregnancy: an underlying Graves' disease triggered by hCG?

      ea0112029
    • Diagnosis of familial dysalbuminemic hyperthyroxinemia in a family initially suspected of thyroid hormone resistance beta

      ea0112030
    • Discovery of a novel form of neonatal diabetes caused by TMEM167A mutations that impair pancreatic [beta] cell function and survival

      ea0112031
    • Familial hyperaldosteronism type I: contribution of long-read DNA sequencing

      ea0112032
    • Infected thyroid metastases revealing advanced metastatic pulmonary cancer: a case report

      ea0112033
    • Thyroid involvement in marginal zone lymphoma: a case report

      ea0112034